National Prescribing Indicators

National Prescribing Indicators
 
The All Wales Medicines Strategy Group (AWMSG) has endorsed the National Prescribing Indicators (NPIs) as a means of promoting safe and cost-effective prescribing.  NPIs have been published since 2003 and have historically focused on primary care prescribing.  In 2015 a set of secondary care NPIs were developed by the All Wales Prescribing Advisory Group (AWPAG) and launched by AWMSG for use in 2016–2017.  For 2016-17, there are 13 primary care NPIs focusing on seven areas of prescribing and the reporting of adverse events (Yellow Cards). Two of the indicators, lipid-regulating drugs and gabapentin and pregabalin, are new for 2016–20
 
The National Prescribing Indicators 2016–2017: Analysis of Prescribing Data to March 2017 document has been prepared by the Welsh Analytical Prescribing Support Unit and can be accessed on the link below:
 
http://www.awmsg.org/docs/awmsg/medman/National%20Prescribing%20Indicators%202016-2017%20Analysis%20of%20Prescribing%20Data%20to%20March%202017.pdf